Symposia of 90 min duration integrate the latest advances in basic, clinical, and translational neuropsychopharmacology, biological psychiatry, drug development public policy issues relevant to mental health, mental illness, and treatment across the lifespan.
Four Speakers including the Chairperson should represent at least three different countries and four different institutions. It is recommended that at least two speakers should be CINP members. Symposia proposals that include female faculty and investigators who obtained their last degree in the last 10 years are greatly encouraged.
The individual who submits the symposium proposal via the submission process below must be the Chairperson of their proposed session.
Submitters can apply for no more than two symposia and speakers can agree to participate in no more than two proposals.
CINP 2022 Symposia will be reviewed and selected on a highly competitive basis by the International Scientific Programme Committee in October 2021. Notifications will be sent to all symposia submitters in November 2021.
Speakers in successful symposia will receive the following entitlements:
|Symposia Submission Deadline||10 October 2021 (23:59 GMT+8)|
|Notification of Submission Acceptance||8 November 2021|
|Deadline for Change of Title/Authorship||10 October 2021|
Abstract submissions must be structured with the following:
For questions regarding the symposia submission, please contact CINP Program Manager at cinp2022-program[at]cinp.org
Stay tuned for more information on upcoming Congresses hosted by the International College of Neuropsychopharmacology (CINP).
Keep up to date with Congress News & Alerts